Veradigm Presentations at ISPOR 2022 Highlight Broader Access to and Integration of Real-world Data Sources
May 11 2022 - 8:01AM
Business Wire
Covid-19 Dashboard highlights risk factors for
unvaccinated, vaccination gaps, and social disparities
Researchers from Veradigm®, a leading provider of healthcare
data and technology solutions, will present health economics and
outcomes research (HEOR) data on Covid-19, diabetes, NASH
(Non-Alcoholic Steatohepatitis), and cardiovascular disease at the
International Society for Pharmacoeconomics and Outcomes Research
(ISPOR) in Washington, D.C. from May 15-18, 2022.
This press release features multimedia. View
the full release here:
https://www.businesswire.com/news/home/20220511005419/en/
“Accessing real-world data from across a variety of sources
provides rich evidence for better decision-making and improved
clinical outcomes for patients,” said Tom Langan, Allscripts
President and Chief Commercial Officer. “We’re pleased to
demonstrate how Veradigm provides tools that contribute to public
health initiatives, like the Covid-19 Dashboard guiding outreach to
underserved communities, or identifying risk factors with research
that supports patients diagnosed with NASH earlier in their
diagnosis or treatment.”
Key data presentations at ISPOR 2022 include:
Covid-19
Real-World Data Dashboard Integrating Public Health & EHR
Data for Identifying COVID-19 Vaccination Gaps in the US. L.
Kallenbach. CODE: EPH60. May 17th 9:45 AM – 1:15 PM EDT.
SARS-COV-2 Vaccine Breakthrough Infection Rates Based Data from
3 EHRS. J. Overcash. CODE: RWD72. May 17th 9:45 AM – 1:15 PM
EDT.
NASH
Assessing Cardiovascular Disease (CVD) Risk By Fibrosis Stage
Defined By Fibrosis-4 (FIB-4) Among Patients with Non-Alcoholic
Steatohepatitis (NASH) Using Real World Data (RWD). A. Bogdanov.
CODE: EPH141. May 18th 9:00 AM – 12:45 PM EDT.
Comparing Fibrosis Staging Approaches Among Patients with
Non-Alcoholic Steatohepatitis (NASH) Using Real World Data (RWD).
A. Bogdanov. CODE: EPH161. May 16th 3:00 – 6:30 PM EDT.
Diabetes
Comparing Techniques for Mining HBA1C Data in Ambulatory EHRS
for Use in RWE Research. N. Nguyen. CODE: RWD52. May 16th 3:00 -
6:30 PM EDT.
Artificial Intelligence (AI)
Categorizing Telemedicine Visits Using Natural Language
Processing and Machine Learning. T. Sudaria. CODE: RWD112. May 17th
3:00 - 6:30 PM EDT.
Evaluating a Privacy Preserving Record Linkage (PPRL) Solution
to Link De-identified Patient Records in RWD Using Default Matching
Methods and Machine Learning Methods. N. Nguyen. CODE: RWD103. May
17th 3:00 - 6:30 PM EDT.
Additional presentations at ISPOR include Veradigm’s
Comparing Registry and Electronic Health Record (EHR) Data for
Real-World Evidence Generation: Heart Failure as a Case Study
on Tuesday, May 17 at 12:45 p.m. EDT. This presentation examines
how generating real-world evidence (RWE) from heart failure
patients requires clinical data elements not commonly found in
administrative databases and has the potential to further
understanding in heart failure management. Data were compared and
contrasted from two different data sources, Veradigm’s PINNACLE®
Registry, a large cardiovascular disease registry developed by the
American College of Cardiology, with those identified in the
Practice Fusion ambulatory electronic health record (EHR)
database.
For more presentation information titles, please visit ISPOR
2022.
About Veradigm®
Veradigm® is a healthcare technology company that drives value
through its unique combination of platforms, data, expertise,
connectivity, and scale. Some healthcare technology companies
deliver clinical data for biopharma and health plans, some help
turn that data into insights, others serve healthcare providers
directly by providing point-of-care clinical software and patient
outreach platforms. Only Veradigm does it all. In combination with
Veradigm’s companies and solutions, the Veradigm Network features a
dynamic community of companies providing advanced insights,
technology, and data-driven solutions, all working together to
transform healthcare insightfully.
For more information on Veradigm, visit www.veradigm.com, or
find Veradigm on LinkedIn, Facebook, Twitter, and YouTube.
About Allscripts
Allscripts (NASDAQ: MDRX) is a leader in healthcare information
technology solutions that advance clinical, financial and
operational results. Our innovative solutions connect people,
places and data across an Open, Connected Community of Health™.
Connectivity empowers caregivers to make better decisions and
deliver better care for healthier populations. To learn more, visit
www.allscripts.com, Twitter, YouTube and It
Takes A Community: The Allscripts Blog.
© 2022 Allscripts Healthcare, LLC and/or its affiliates. All
Rights Reserved.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20220511005419/en/
Investors: Jenny Gelinas
312-506-1237 Jenny.Gelinas@allscripts.com
Media: Concetta Rasiarmos
312-447-2466 concetta.rasiarmos@allscripts.com
Veradigm (NASDAQ:MDRX)
Historical Stock Chart
From Mar 2024 to Apr 2024
Veradigm (NASDAQ:MDRX)
Historical Stock Chart
From Apr 2023 to Apr 2024